DB

Dhampur Bio Organics Ltd

Q4 FY26Agricultural Food & other Products

Dhampur Bio Organics Q4 FY26: Revenue ₹552.44 Cr, PAT ₹46.00 Cr

Q4 FY26 investor presentation: what the company reported on revenue, margins and projects.

Price₹113
Market cap₹772 Cr
P/E30.2
Updated24 Sept 2026
Read4 min read

Based on Dhampur Bio Organics Ltd's Q4 FY26 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the presentation reports, not management guidance.

The short version

Revenue (Net of Excise) for Q4FY26: ₹552.44 Crores, up 19.06% YoY from ₹464.01 Crores (Page 10). Q4FY26 EBITDA: ₹102.44 Crores, up 3% YoY (from ₹99.54 Crores in Q4FY25) - Q4FY26 EBITDA Margin: 18.54%, down 291 bps YoY (from 21.45% in Q4FY25) - Q4FY26 PAT: ₹46.00 Crores, up 16% YoY (from ₹39.6

From Dhampur Bio Organics Ltd's Q4 FY26 earnings-call transcript · updated 24 Sept 2026.

Revenue & Sales Performance

  • Revenue (Net of Excise) for Q4FY26: ₹552.44 Crores, up 19.06% YoY from ₹464.01 Crores (Page 10).
  • Sugar sales revenue Q4FY26: ₹496.24 Crores, increased 11.98% YoY (Page 18).
  • Sugar sales volume Q4FY26: 97,909 tons vs 67,282 tons Q4FY25 (Page 19).
  • Biofuel & Spirits revenue Q4FY26: ₹94.41 Crores, down 18.79% YoY (Page 18).
  • Country Liquor sales volume Q4FY26: 9,78,330 cases vs 10,78,251 cases Q4FY25 (Page 23).

2 more points management made on revenue & sales performance

Profitability & Margins

See what Dhampur Bio Organics Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

The presentation does not explicitly detail any capex amounts, capacity expansions, or new plants/projects with specified status or timelines. However, the following points are noted: - Meerganj Plant: Company has entered into a business transfer agreement for the sale of business undertaking at Meerganj Unit on April 20, 2026 (Page 7). - No specific capex plans, investments, or new project timelines are described in the presentation. - Capacity details are provided for existing plants but no mention of expansion or upgrades:

2 more points management made on capital expenditure plans

Top-ranked in Agricultural Food & other Products

Ranked on what management guided this quarter

5x potential
Rev 1Mar 2
Rev 1Mar 3
3
Rev 2Mar 1
4
Rev 2Mar 1
5
Rev 2Mar 2
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Dhampur Bio Organics Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The investor presentation for Dhampur Bio Organics Limited does not report any information regarding: - Order book - Order inflow - Pending orders The presentation primarily details financial results, operational highlights, segmental performance, ESG strategy, shareholder information, and company contact details. There is no mention or data provided on order book status, order inflow, or pending orders in the entire document.

Dhampur Bio Organics Ltd — Quarterly revenue & net profit

Revenue Net profit Net loss
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025

Reported quarterly figures (₹ Cr). Latest: revenue ₹486 Cr, net profit ₹17 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Agricultural Food & other Products this season

  • Uttam Sugar Mills Ltd (Q4 FY26)

    Consolidated: ₹471.87 Cr (Q4 FY26) vs ₹569.13 Cr (Q4 FY25), ↓ ~17.1% YoY . Key concall takeaways from Uttam Sugar Mills Ltd's Q4 FY26 earnings call — and how…

  • GRM Overseas Ltd (Q4 FY26)

    597.2 Crores vs. Key concall takeaways from GRM Overseas Ltd's Q4 FY26 earnings call — and how it ranks against sector peers.

  • Amir Chand Jagdish Kumar (Exports) Ltd (Q4 FY26)

    694.7 Cr . Key concall takeaways from Amir Chand Jagdish Kumar (Exports) Ltd's Q4 FY26 earnings call — and how it ranks against sector peers.

  • Sanstar Ltd (Q4 FY26)

    2,168 million, down 4.2% YoY (compared to Rs. Key concall takeaways from Sanstar Ltd's Q4 FY26 earnings call — and how it ranks against sector peers.

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Dhampur Bio Organics Ltd Q4 FY26 results?

Revenue (Net of Excise) for Q4FY26: ₹552.44 Crores, up 19.06% YoY from ₹464.01 Crores (Page 10). Q4FY26 EBITDA: ₹102.44 Crores, up 3% YoY (from ₹99.54 Crores in Q4FY25) - Q4FY26 EBITDA Margin: 18.54%, down 291 bps YoY (from 21.45% in Q4FY25) - Q4FY26 PAT: ₹46.00 Crores, up 16% YoY (from ₹39.6

What is Dhampur Bio Organics Ltd share price analysis?

Dhampur Bio Organics Ltd currently shows a neutral. The stock trades at a P/E of 30.2 with a market cap of ₹772 Cr. Investors should review the full earnings analysis for detailed insights.

Is Dhampur Bio Organics Ltd planning capital expenditure?

The presentation does not explicitly detail any capex amounts, capacity expansions, or new plants/projects with specified status or timelines.

Keep Dhampur Bio Organics Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.